Evidence map›Paper›PMID 36893849›Full record

ReviewMolecular and cellular neurosciences2023

Transcriptional and epigenetic regulation of microglia in substance use disorders.

Samara J Vilca, Alexander V Margetts, Tate A Pollock, Luis M Tuesta

Open access · greenAbstract readReview
In one paragraph

Review in Molecular and cellular neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Neuroscience and addiction research: current advances and perspectives.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Samara J VilcaDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America; Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America.
Alexander V MargettsDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America; Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America.
Tate A PollockDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America; Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America.
Luis M TuestaDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America; Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, United States of America. Electronic address: ltuesta@miami.edu.
University of Miami · US

Funding

Microglia and Epigenetic Regulation in Opioid AddictionDP1DA051828 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TUESTA, LUIS MIGUEL · 2020 to 2024
$2.3M
Role of Dopamine Neuron-Specific Gene Enhancers in Cocaine RelapseK01DA045294 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TUESTA, LUIS MIGUEL · 2018 to 2022
$955k
Investigating the Role of Microglia in Methamphetamine Use DisorderF99NS130871 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI VILCA, SAMARA JO · 2022 to 2022
$48k
NIDA NIH HHS DP1 DA051828NIDA NIH HHS K01 DA045294NINDS NIH HHS F99 NS130871
6 · The paper itself

Abstract

Microglia are widely known for their role in immune surveillance and for their ability to refine neurocircuitry during development, but a growing body of evidence suggests that microglia may also play a complementary role to neurons in regulating the behavioral aspects of substance use disorders. While many of these efforts have focused on changes in microglial gene expression associated with drug-taking, epigenetic regulation of these changes has yet to be fully understood. This review provides recent evidence supporting the role of microglia in various aspects of substance use disorder, with particular focus on changes to the microglial transcriptome and the potential epigenetic mechanisms driving these changes. Further, this review discusses the latest technical advances in low-input chromatin profiling and highlights the current challenges for studying these novel molecular mechanisms in microglia.

Indexed as

MicrogliaSubstance-Related DisordersChromatinEpigenesis, GeneticHumansTranscriptomeChromatinChromatinCravingEpigeneticsGenomicsHistoneMicrogliaOpioidsSelf-administrationStimulantsSubstance use disordersTranscription

Identifiers

PMID36893849
PMCPMC10247513
OpenAlexW4323350548

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.